|
|
Volumn 11, Issue 3, 2003, Pages 133-134
|
|
Cannabinoids in supportive care: Are they necessary?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIEMETIC AGENT;
ANTINEOPLASTIC AGENT;
CANNABINOID;
CANNABINOID 1 RECEPTOR;
CANNABINOID 2 RECEPTOR;
CANNABINOID RECEPTOR;
DEXAMETHASONE;
LEVONANTRADOL;
METOCLOPRAMIDE;
NABILONE;
NEUROKININ 1 RECEPTOR ANTAGONIST;
SEROTONIN 3 ANTAGONIST;
SEROTONIN 3 RECEPTOR;
TETRAHYDROISOQUINOLINE DERIVATIVE;
APPETITE STIMULANT;
DRUG RECEPTOR;
ENDOCANNABINOID;
UNSATURATED FATTY ACID;
ADVANCED CANCER;
ATAXIA;
AUTONOMIC NERVOUS SYSTEM;
CANCER CHEMOTHERAPY;
CANCER PALLIATIVE THERAPY;
CANCER PATIENT;
CENTRAL NERVOUS SYSTEM;
CHEMOTHERAPY INDUCED EMESIS;
CLINICAL TRIAL;
DEPERSONALIZATION;
DOSE RESPONSE;
DRUG EFFECT;
DRUG INDICATION;
DRUG MECHANISM;
DRUG MEGADOSE;
DRUG RECEPTOR BINDING;
DRUG SYNTHESIS;
DYSPHORIA;
EDITORIAL;
HALLUCINATION;
HUMAN;
HYPOTENSION;
NAUSEA AND VOMITING;
NEUROTOXICITY;
NEUROTRANSMISSION;
PERCEPTION DISORDER;
PRIORITY JOURNAL;
SOMNOLENCE;
THOUGHT DISORDER;
VERTIGO;
VISUAL IMPAIRMENT;
CACHEXIA;
CENTRAL NERVOUS SYSTEM DISEASE;
CHEMICALLY INDUCED DISORDER;
MEDICAL ETHICS;
NAUSEA;
NEOPLASM;
NOTE;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
APPETITE STIMULANTS;
CACHEXIA;
CANNABINOIDS;
CENTRAL NERVOUS SYSTEM DISEASES;
ENDOCANNABINOIDS;
ETHICS, CLINICAL;
FATTY ACIDS, UNSATURATED;
HUMANS;
NAUSEA;
NEOPLASMS;
RECEPTORS, CANNABINOID;
RECEPTORS, DRUG;
TREATMENT OUTCOME;
|
|
EID: 0037531288
PISSN: 09414355
EISSN: None
Source Type: Journal
DOI: 10.1007/s00520-002-0431-7 Document Type: Editorial |
|
Times cited : (9)
|
|
References (6)
|
